Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of PTC Therapeutics Inc (NASDAQ: PTCT) was $35.48 for the day, up 1.17% from the previous closing price of $35.07. In other words, the price has increased by $1.17 from its previous closing price. On the day, 0.61 million shares were traded. PTCT stock price reached its highest trading level at $36.9 during the session, while it also had its lowest trading level at $35.09.
Ratios:
Our analysis of PTCT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.17 and its Current Ratio is at 2.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $44.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 16 ’24 when Gravier Pierre sold 2,269 shares for $34.02 per share. The transaction valued at 77,200 led to the insider holds 53,531 shares of the business.
ZELDIS JEROME B sold 20,000 shares of PTCT for $764,800 on May 22 ’24. The Director now owns 14,500 shares after completing the transaction at $38.24 per share. On May 07 ’24, another insider, Golden Lee Scott, who serves as the EVP & CHIEF MEDICAL OFFICER of the company, sold 175 shares for $32.82 each. As a result, the insider received 5,744 and left with 59,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 2729270528 and an Enterprise Value of 4116360448. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.03. Its current Enterprise Value per Revenue stands at 4.571 whereas that against EBITDA is 323.639.
Stock Price History:
Over the past 52 weeks, PTCT has reached a high of $40.69, while it has fallen to a 52-week low of $17.53. The 50-Day Moving Average of the stock is 7.07%, while the 200-Day Moving Average is calculated to be 15.85%.
Shares Statistics:
PTCT traded an average of 690.92K shares per day over the past three months and 572900 shares per day over the past ten days. A total of 75.71M shares are outstanding, with a floating share count of 74.40M. Insiders hold about 3.29% of the company’s shares, while institutions hold 103.40% stake in the company. Shares short for PTCT as of 1724976000 were 5625708 with a Short Ratio of 8.14, compared to 1722384000 on 5735419. Therefore, it implies a Short% of Shares Outstanding of 5625708 and a Short% of Float of 11.3900006.
